Open AccessMonotherapy with a A2A Adenosine Receptor Antagonist Reduces Tumor Volume in a 4-NQO-induced Head and Neck Cancer (HNC) Mouse Model
Author(s) -
Sonja Ludwig,
CS Hong,
Beatrice Razzo,
Kellsye P. Fabian,
Manoj Chelvanambi,
S Lang,
Walter J. Storkus,
Whiteside Tl
Publication year - 2019
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0039-1686026
Subject(s) - head and neck cancer , antagonist , adenosine a2a receptor , adenosine , adenosine receptor , head and neck , medicine , cancer , receptor , cancer research , chemistry , agonist , surgery